(IBTK) iShares iBonds Dec 2030 - Ratings and Ratios
Treasury Bonds, Cash Equivalents, Money Market
| Risk via 10d forecast | |
|---|---|
| Volatility | 2.99% |
| Value at Risk 5%th | 4.84% |
| Relative Tail Risk | -1.84% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.68 |
| Alpha | 3.45 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.475 |
| Beta | -0.037 |
| Beta Downside | -0.063 |
| Drawdowns 3y | |
|---|---|
| Max DD | 8.51% |
| Mean DD | 2.26% |
| Median DD | 1.92% |
Description: IBTK iShares iBonds Dec 2030 October 25, 2025
The iShares iBonds Dec 2030 Term Treasury ETF (IBTK) tracks the ICE 2030 Maturity U.S. Treasury Index, holding publicly-issued U.S. Treasury securities that mature between 1 Jan 2030 and 15 Dec 2030. The fund may also allocate a modest portion to short-term paper, cash, and money-market shares to manage liquidity.
Key metrics as of the latest reporting period: expense ratio ≈ 0.20 %, weighted-average maturity ≈ 2030, and a 30-day SEC yield around 4.3 % (reflecting the current 10-year Treasury rate). The ETF’s performance is highly sensitive to Federal Reserve policy-particularly changes in short-term rates and the shape of the yield curve-as well as fiscal-deficit dynamics that influence Treasury issuance volumes.
For a deeper dive into how IBTK fits into a broader portfolio, you might explore the analytics on ValueRay.
IBTK ETF Overview
| Market Cap in USD | 580m |
| Category | Target Maturity |
| TER | 0.07% |
| IPO / Inception | 2020-07-14 |
| Return 12m vs S&P 500 | -5.75% |
| Analyst Rating | - |
IBTK Dividends
| Metric | Value |
|---|---|
| Dividend Yield | 3.81% |
| Yield on Cost 5y | 3.52% |
| Yield CAGR 5y | 85.27% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
IBTK Growth Ratios
| Metric | Value |
|---|---|
| CAGR 3y | 3.94% |
| CAGR/Max DD Calmar Ratio | 0.46 |
| CAGR/Mean DD Pain Ratio | 1.74 |
| Current Volume | 165.2k |
| Average Volume | 130.3k |
What is the price of IBTK shares?
Over the past week, the price has changed by -0.05%, over one month by -0.18%, over three months by +1.67% and over the past year by +7.06%.
Is IBTK a buy, sell or hold?
What are the forecasts/targets for the IBTK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 21.6 | 8.4% |
IBTK Fundamental Data Overview November 19, 2025
Beta = 0.97
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 579.7m USD (579.7m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 579.7m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 579.7m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 5.88% (E(579.7m)/V(579.7m) * Re(5.88%) + (debt-free company))
Discount Rate = 5.88% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for IBTK ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle